Therapy pack

Abstract

A blister card provides for combined morning, afternoon, and bedtime doses of two tablets or capsules, respectively, of a muscle relaxant drug such as cyclobenzaprine hydrochloride, and an NSAID such as etodolac. The number of blister cards required for a given number of days of therapy are packaged together in a carton for the convenience of the patient.

What I claim is:  
     
         1 . A therapy pack for providing a prescribed combined daily oral dose of muscle relaxant drug tablets or capsules and a nonsteroidal anti-inflammatory drug (NSAID) capsules or tablets, comprising: 
 a blister card including at least one pair of blister cells, with each pair including one cell for containing a prescribed single oral dose strength of said muscle relaxant, and one cell for containing a prescribed single oral dose strength of said NSAID for providing a combined dose thereof at a given time.    
     
     
         2 . The therapy pack of  claim 1 , further including a plurality of said blister cards for providing a prescribed multiple day treatment.  
     
     
         3 . The therapy pack of  claim 2 , wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID is etodolac.  
     
     
         4 . The therapy pack of  claim 2 , further including a carton for containing said plurality of said blister cards for individual disbursement for each daily or day's treatment.  
     
     
         5 . The therapy pack of  claim 1 , wherein three of said pairs of blister cells are provided, with each being designated by indicia on the associated blister card for morning, afternoon, and bedtime combined doses, respectively.  
     
     
         6 . The therapy pack of  claim 5 , wherein each of said three pairs of blister cells are arranged in three successive rows.  
     
     
         7 . The therapy pack of  claim 6 , wherein each blister cell of each pair of blister cells is arranged in a column, thereby forming first and second spaced apart columns.  
     
     
         8 . The therapy pack of  claim 7 , wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID is etodolac.  
     
     
         9 . The therapy pack of  claim 8 , wherein said first and second columns are labeled via indicia on said blister card as “Cyclobenzaprine”, and “Etodolac”, respectively.  
     
     
         10 . The therapy pack of  claim 7 , wherein it is further indicated by indicia that each blister cell of said first column contains 10 milligrams of cyclobenzaprine, and of said second column contains 330 milligrams of etodolac.  
     
     
         11 . The therapy pack of  claim 3 , wherein 10 milligrams is the prescribed single dose of cyclobenzaprine hydrochloride, and 330 milligrams is the prescribed single dose of etodolac.  
     
     
         12 . A blister card for providing a single days prescribed multiple and time separated combined doses of muscle relaxant drug tablets, and nonsteroidal anti-inflammatory drug (NSAID) capsules or tablets, comprising: 
 a plurality of pairs of blister cells arranged into first and second columns and a plurality of rows;    said first column of blister cells each containing a single dose tablet or capsule of muscle relaxant; and    said second column of blister cells each containing a single dose tablet or capsule of NSAID.    
     
     
         13 . The blister card of  claim 12 , wherein said muscle relaxant drug is cyclobenzaprine hydrochloride, and said NSAID capsule or tablet is etodolac.  
     
     
         14 . The blister card of  claim 12 , wherein said first column of blister cells is identified by indicia thereon as each containing “Cyclobenzaprine 10 mg,” and said second column is identified by indicia thereon as each containing “Etodolac 330 mg.” 
     
     
         15 . The blister card of  claim 12 , wherein first and second columns of blister cells are spaced apart, and said plurality of pairs of blister cells are arranged into three rows labeled by indicia as “MORNING”, “AFTERNOON”, and “BEDTIME,” respectively.  
     
     
         16 . The blister card of  claim 14 , wherein said first and second columns of blister cells are spaced apart, and said plurality of pairs of blister cells are arranged into three rows labeled by indicia as “MORNING”, “AFTERNOON”, and “BEDTIME,” respectively.  
     
     
         17 . A therapy pack for providing a prescribed combined daily oral dose of tablets or capsules of the muscle relaxant drug cyclobenzaprine, and the nonsteroidal anti-inflammatory drug (NSAID) etodolac comprising: 
 a blister card including at least one pair of blister cells, with each pair including one cell for containing a prescribed single oral dose strength of said muscle relaxant and one cell for containing a prescribed single oral dose strength of said NSAID for providing a combined dose thereof at a given time.    
     
     
         18 . The therapy pack of  claim 17 , further including a plurality of said blister cards for providing a prescribed multiple day treatment.  
     
     
         19 . The therapy pack of  claim 18 , further including a carton for containing said plurality of said blister cards for individual disbursement for each daily or day's treatment.  
     
     
         20 . The therapy pack of  claim 17 , wherein said three pairs of blister cells are designated by indicia printed on the associated blister card for identifying morning, afternoon, and bedtime combined doses, respectively.  
     
     
         21 . The therapy pack of  claim 20 , wherein each of said three pairs of blister cells are arranged in three successive rows.  
     
     
         22 . The therapy pack of  claim 21 , wherein each blister cell of each pair of blister cells is arranged in a column, thereby forming first and second spaced apart columns.  
     
     
         23 . The therapy pack of  claim 22 , wherein said first and second columns are labeled via indicia on said blister card as cyclobenzaprine and etodolac, respectively.  
     
     
         24 . The therapy pack of  claim 23 , wherein it is further indicated by said indicia that each blister cell of said first column contains a 10 milligram dose of cyclobenzaprine, and each blister cell of said second column contains a 330 milligram dose of etodolac.  
     
     
         25 . The therapy pack of  claim 17 , wherein 10 milligrams is the prescribed single dose of cyclobenzaprine hydrochloride, and 330 milligrams is the prescribed single dose of etodolac.  
     
     
         26 . A blister card for providing a single days prescribed three time separated combined doses of cyclobenzaprine hydrochloride capsules or tablets, and etodolac capsules or tablets, comprising: 
 three pairs of blister cells arranged into first and second columns and three rows;    said first column of blister cells each containing a single dose tablet or capsule of cyclobenzaprine hydrochloride; and    said second column of blister cells each containing a single dose tablet or capsule of etodolac.    
     
     
         27 . The blister card of  claim 26 , wherein a single dose tablet of cyclobenzaprine hydrochloride contains 10 milligrams thereof, and a single dose capsule or tablet of etodolac contains 330 milligrams thereof.  
     
     
         28 . The blister card of  claim 26 , wherein said first column of blister cells is identified by indicia thereon as each containing “Cyclobenzaprine 10 mg,” and a second column is identified by indicia thereon as each containing “Etodolac 330 mg.” 
     
     
         29 . The blister card of  claim 26 , wherein said columns of blister cells are spaced apart, and each of said three rows are labeled by indicia as “MORNING”, “AFTERNOON”, and “BEDTIME,” respectively.  
     
     
         30 . The blister card of  claim 28 , wherein said columns of blister cells are spaced apart, and each of said three rows are labeled by indicia as “MORNING”, “AFTERNOON”, and “BEDTIME,” respectively.